Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer's disease.
The journal of prevention of Alzheimer's disease
View this publicationThe journal of prevention of Alzheimer's disease
View this publicationInternational journal of molecular sciences
View this publicationCell reports
View this publicationCell death & disease
View this publicationCirculation. Cardiovascular interventions
View this publicationHGG advances
View this publicationFrontiers in immunology
View this publicationEuropean journal of human genetics : EJHG
View this publicationHaemophilia : the official journal of the World Federation of Hemophilia
View this publicationiScience
View this publication